SelectSecure 3830 Lead Imaging

NCT ID: NCT03941275

Last Updated: 2022-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-24

Study Completion Date

2021-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects undergoing bi-plane fluoroscopy

Bi-plane fluoroscopy

Intervention Type DIAGNOSTIC_TEST

In vivo acquisition of biplane cine radiographic images of the market released Medtronic SelectSecure 3830 pacing lead

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bi-plane fluoroscopy

In vivo acquisition of biplane cine radiographic images of the market released Medtronic SelectSecure 3830 pacing lead

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are at least 18 years of age
* Patient has a pacing, ICD or CRT system incorporating at least one SelectSecure 3830 lead in the right atrium or right ventricle
* Patients able and willing to attend imaging session
* Patients able and willing to give informed consent
* Pacing capture threshold and pacing impedance of the lead are within normal range at the time of enrollment
* Patient must be able to accomplish arm flexion and adduction past 90 degrees

Exclusion Criteria

* Subjects who require a legally authorized representative to obtain consent
* Pregnant women, or women of child bearing potential and who are not on a reliable form of birth control
* Subjects that were implanted with a pacing, ICD, CRT device and/or cardiac leads less than three months ago
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart Center Research

Huntsville, Alabama, United States

Site Status

Iowa Heart Center

West Des Moines, Iowa, United States

Site Status

Associates in Cardiology PA

Silver Spring, Maryland, United States

Site Status

Lourdes Cardiology Services

Voorhees Township, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDT18066

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Abbott Brady 3T MRI PMCF
NCT03786640 COMPLETED
PANORAMA Observational Study
NCT00382525 COMPLETED
Image Supported Lead Placement in CRT
NCT05053568 ACTIVE_NOT_RECRUITING NA